Alright, should we do this? I'm going to attempt my first mini-#tweetatorial on this little capsule right here... #hydroxyurea is currently the mainstay of disease modifying therapy in #sicklecell disease and with the new landscape of therapeutics, I think we should dive in /1

1/ Last night my wife and I made the decision to cancel my 7-year-old daughter's gymnastics birthday party this weekend due to #COVID19. Why? How did she react? A thread from an ER doc/scientist who doesn’t freak out about most things:

Coronavirus Act Now covidactnow.org

See a forecast for how long each US state has until COVID-19 overwhelms hospitals and how interventions could flatten the curve: covidactnow.org #COVIDActNow

#COVID19 course in 1 slide OncoAlert

Simply the best 👇 Opinion | Dave Eggers: Flattening the Truth on Coronavirus - The New York Times nytimes.com/2020/05/03/opi…

I finished reading the Remdesivir trial If you want my thoughts you will have to read this thread [Thread]

Remdesivir for the Treatment of Covid-19 — Preliminary Report | NEJM nejm.org/doi/full/10.10…

For years, the last handout I give the students in my fourth year course has been (totally shameless, unsought) life advice. This AM, seeing patients, reflecting on things I really love about my job, I decided to update them. Felt the need to share before next February.

RETWEET THIS! We want 1 million fans to wish the Kansas City Chiefs good luck in Sunday’s AFC Championship game. Plus, send some love to Patrick Mahomes II. For every person who retweets this, we’ll donate $1 to the quarterback’s charity 15 and the Mahomies (up to $100k). #RunItBack #HyVeePlayoffs

Incredible !!!

So honored to receive the abstract achievement award by ASH for our project formulating a 9point in-pt bleeding risk score for patients on DOACs! Thank you Anuj Shrestha, MD, FACP for all your mentorship and my awesome statistical team at UMKC School of Medicine !

Kansas City Bleeding Index - clinical tool for predicting bleeding risk for patient on DOAC therapy #ASH22 ⁦Sumaiya Alam, MD⁩ ⁦UMKC School of Medicine⁩ ⁦University Health⁩ ⁦UMKC⁩

Meeting the UMKC hem/onc fellowship alumni and the classical hematology pose #ASH22 ⁦University Health⁩ ⁦UMKC⁩

Great meeting with medical school buddies #MCOMS #ASH22 ⁦Anuj Shrestha, MD, FACP⁩ ⁦Prashant Sharma, MD, FACP⁩

Feeling excited to present award winning research poster at ASH 2023 delineating incidence of DVT, hemorrhage and infection in patients with bleeding disorders after arthroplasty. Sincere thanks to my mentor Anuj Shrestha, MD, FACP and UMKC Bioinformatics team. #ASH23 #UMKC #MedEd

Hepatology 🔁 Oncology Rare presentation of #Hodgkin lymphoma as vanishing bile duct syndrome 🪄 Great work by Himil Mahadevia, MBBS and immensely grateful for Anuj Shrestha, MD, FACP’s mentorship casereports.bmj.com/content/17/5/e…

Excited to present our research at the #ASCOQLTY24 Grateful to my mentor Anuj Shrestha, MD, FACP for this opportunity and UMKC Bioinformatics team for their support!!! ASCO UMKC Internal Medicine Residency Program Priyanka Sharma #hemoncaspirant Hem-Onc Fellows Network

Excited to celebrate the outstanding fellowship match results of our UMKC Internal Medicine residents! We’re proud of your achievements and look forward to your continued success in the next chapter of your careers. #UMKCIM #FellowshipMatch2024

Happy to share our literature review on current and upcoming pharmacologic drugs for Sickle cell disease published in Annals of Hematology - link.springer.com/article/10.100… UMKC Internal Medicine Residency Program Ben Ponvilawan, MD, MS Ujjwal Madan, MD Parth Sharma Anuj Shrestha, MD, FACP #Hematology #HemeTwitter #MedTwitter #MedEd